Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity
- PMID: 22836048
- PMCID: PMC3646086
- DOI: 10.1016/j.ijrobp.2012.06.040
Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity
Abstract
Purpose: Poor pulmonary function (PF) is often considered a contraindication to definitive radiation therapy for lung cancer. This study investigated whether baseline PF was associated with radiation-induced lung toxicity (RILT) in patients with non-small cell lung cancer (NSCLC) receiving conformal radiation therapy (CRT).
Methods and materials: NSCLC patients treated with CRT and tested for PF at baseline were eligible. Baseline predicted values of forced expiratory volume in 1 sec (FEV1), forced vital capacity (FVC), and diffusion capacity of lung for carbon monoxide (DLCO) were analyzed. Additional factors included age, gender, smoking status, Karnofsky performance status, coexisting chronic obstructive pulmonary disease (COPD), tumor location, histology, concurrent chemotherapy, radiation dose, and mean lung dose (MLD) were evaluated for RILT. The primary endpoint was symptomatic RILT (SRILT), including grade ≥2 radiation pneumonitis and fibrosis.
Results: There was a total of 260 patients, and SRILT occurred in 58 (22.3%) of them. Mean FEV1 values for SRILT and non-SRILT patients were 71.7% and 65.9% (P=.077). Under univariate analysis, risk of SRILT increased with MLD (P=.008), the absence of COPD (P=.047), and FEV1 (P=.077). Age (65 split) and MLD were significantly associated with SRILT in multivariate analysis. The addition of FEV1 and age with the MLD-based model slightly improved the predictability of SRILT (area under curve from 0.63-0.70, P=.088).
Conclusions: Poor baseline PF does not increase the risk of SRILT, and combining FEV1, age, and MLD may improve the predictive ability.
Published by Elsevier Inc.
Conflict of interest statement
None of authors have conflict of interest.
Figures
Similar articles
-
Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e537-43. doi: 10.1016/j.ijrobp.2012.01.019. Epub 2012 Mar 13. Int J Radiat Oncol Biol Phys. 2012. PMID: 22420964 Free PMC article.
-
Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.Strahlenther Onkol. 2020 Jun;196(6):505-514. doi: 10.1007/s00066-019-01552-4. Epub 2019 Dec 11. Strahlenther Onkol. 2020. PMID: 31828393
-
Pulmonary function changes following helical tomotherapy in patients with inoperable, locally advanced non-small cell lung cancer.Strahlenther Onkol. 2020 Feb;196(2):142-150. doi: 10.1007/s00066-019-01489-8. Epub 2019 Jul 12. Strahlenther Onkol. 2020. PMID: 31300831 Clinical Trial. English.
-
Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):5-24. doi: 10.1016/j.ijrobp.2005.03.047. Int J Radiat Oncol Biol Phys. 2005. PMID: 15963660 Review.
-
Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):172-187. doi: 10.1016/j.ijrobp.2018.11.028. Epub 2018 Nov 26. Int J Radiat Oncol Biol Phys. 2021. PMID: 30496880 Free PMC article. Review.
Cited by
-
Establishment and Verification of a Prediction Model for Symptomatic Radiation Pneumonitis in Patients with Esophageal Cancer Receiving Radiotherapy.Med Sci Monit. 2021 May 6;27:e930515. doi: 10.12659/MSM.930515. Med Sci Monit. 2021. PMID: 33953150 Free PMC article.
-
Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer.PLoS One. 2018 Oct 4;13(10):e0204734. doi: 10.1371/journal.pone.0204734. eCollection 2018. PLoS One. 2018. PMID: 30286105 Free PMC article.
-
Comorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer.Radiat Oncol. 2018 Nov 3;13(1):213. doi: 10.1186/s13014-018-1156-1. Radiat Oncol. 2018. PMID: 30390700 Free PMC article.
-
Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a review.Int J Clin Oncol. 2019 Aug;24(8):899-909. doi: 10.1007/s10147-019-01432-y. Epub 2019 Apr 1. Int J Clin Oncol. 2019. PMID: 30937620 Review.
-
Radiation-induced lung injury: current evidence.BMC Pulm Med. 2021 Jan 6;21(1):9. doi: 10.1186/s12890-020-01376-4. BMC Pulm Med. 2021. PMID: 33407290 Free PMC article. Review.
References
-
- Kong FM, Ten Haken RK, Schipper MJ, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63:324–333. - PubMed
-
- Bradley J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:318–328. - PubMed
-
- Rosenzweig KE, Fox JL, Yorke E, et al. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer. 2005;103:2118–2127. - PubMed
-
- Zhao L, Wang L, Ji W, et al. Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan. Int J Radiat Oncol Biol Phys. 2009;74:1385–1390. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials